Načítá se...

Abiraterone in the treatment of metastatic castration-resistant prostate cancer

Androgen deprivation therapy remains the single most effective treatment for the initial therapy of advanced prostate cancer, but is uniformly marked by progression to castration-resistant prostate cancer (CRPC). Residual tumor androgens and androgen axis activation are now recognized to play a prom...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Mostaghel, Elahe A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912049/
https://ncbi.nlm.nih.gov/pubmed/24501545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S39318
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!